Doctor Tonje Thorvaldsen
Karolinska Institutet, Stockholm (Sweden)
Eligibility for EMPEROR trials in a real-world heart failure population: data from the Swedish heart failure registry
Event: Heart Failure 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Rapid Fire 4 - Chronic heart failure - Pharmacology
Predicting risk in patients hospitalized for acute decompensated heart failure and preserved ejection fraction (from the ARIC study community surveillance)
Event: ESC Congress 2016
Topic: Prognosis
Session: Heart failure / LV dysfunction
ESC 365 is supported by
